UnitedHealth Group Inc (UNH) receives a strong valuation ranking of 72 from InvestorsObserver's data analysis. The proprietary ranking system focuses on the underlying health of a company through analysis of its stock price, earnings, and growth rate. UNH has a better value than 72% of stocks based on these valuation analytics. Investors primarily focused on buy-and-hold strategies will find the valuation ranking relevant to their goals when making investment decisions.
Metrics Analysis
UNH's trailing-12-month Price to Earnings (PE) ratio of 22.7 puts it above the historical average of roughly 15. UNH is a poor value at its current trading price as investors are paying more than what its worth in relation to the company's earnings. UNH's trailing-12-month earnings per share (EPS) of 16.03 does not justify what it is currently trading at in the market. Trailing PE ratios, however, do not factor in a company's projected growth rate, resulting in some firms having high PE ratios due to high growth potentially enticing investors even if current earnings are low.
UNH's 12-month-forward PE to Growth (PEG) ratio of 1.6 is considered a poor value as the market is overvaluing UNH in relation to the company's projected earnings growth due. UNH's PEG comes from its forward price to earnings ratio being divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. Due to their incorporation of more fundamentals of a company's overall health and focusing on the future rather than the past, PEG ratios are one of the most used valuation metrics by analysts today.
Summary
UNH's valuation metrics are weak at its current price due to a overvalued PEG ratio despite strong growth. UNH's PE and PEG are worse than the market average resulting in a below average valuation score.
Click Here to get the full Stock Score Report on UnitedHealth Group Inc (UNH) Stock.
